Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Single/multiple Dosing, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety/tolerability, Pharmacokinetic/pharmacodynamic Characteristics and Food Effect After Oral Administration of IN-114199 in Healthy Participants
Conditions
Interventions
IN-114199 2.5mg or placebo
IN-114199 10mg or placebo
+3 more
Locations
1
South Korea
Seoul National University Hospital, Clinical Trial Center
Seoul, South Korea
Start Date
December 16, 2024
Primary Completion Date
August 30, 2025
Completion Date
November 11, 2025
Last Updated
December 17, 2024
NCT04838522
NCT03879239
NCT02819297
NCT03097861
NCT01982240
NCT03551873
Lead Sponsor
HK inno.N Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions